Latest Breaking News On - Sumant kulkarni - Page 1 : comparemela.com

BioXcel Therapeutics, Inc (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript

BioXcel Therapeutics, Inc (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesRob risingerRam selvarajuCanaccord genuityVimal mehtaSumant kulkarniRichard steinhartAvantika joshiFrank yoccaAlec stranahanMatt wileyColin bristowVince oneillVincent oneillProduct developmentBioxcel therapeutics inc

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCity ofUnited kingdomTeri loxamCanaccord genuityVikram purohit morgan stanleySumant kulkarni canaccord genuityCharles duncanElemer piros rodmanKabir nathMike goldPatrick trucchioElemer pirosCharles duncan cantor fitzgeraldSumant kulkarni

StockWatch: Amgen Throws Its Weight Behind Obesity Drug

StockWatch: Amgen Throws Its Weight Behind Obesity Drug
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesLars fruergaardEvan david seigermanNovo nordiskSumant kulkarniWilliam blairMatt phippsAnnovis bioMaridebart cafraglutide maritideBrianp skorneyTerence flynn morgan stanleyGregory renzaMichaelj yeeJames jay bradnerRoberta bradway amgen

StockWatch: Biogen Q1 Results Beat Expectations, for a Change

StockWatch: Biogen Q1 Results Beat Expectations, for a Change
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSumant kulkarniMichaelj yeeBrianp skorneyChristophera viehbacherSarah schramLaura chicoMichael mcdonnellCanaccord genuityMylesr minterWilliam blairSrikripa devarakonda truistMarc goodmanOmri geller

Zevra Therapeutics, Inc (NASDAQ:ZVRA) Q4 2023 Earnings Call Transcript

Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2.

Sumant kulkarniNeil mcfarlaneChristal mickleJonathan aschoffOren livnatLaduane cliftonJoshua schaferNichol ochsnerCorporate communications for zevra therapeuticsDrug enforcement administrationBusiness developmentUnidentified company representativeZevra therapeutics incInnovation mc groupZevra therapeuticsCall transcript march